Skip Navigation

Vaccine Safety Bibliography - February 2011

1.   Progress in immunization information systems --- United States, 2009. MMWR Morb Mortal Wkly Rep. 2011 Jan 14; 60(1):10-2.

2.   Retraction. ACOG Committee Opinion No. 281: Rubella vaccination. Obstet Gynecol. 2011 Jan; 117(1):191.

3.   Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011 Jan 14; 60(1):13-5.

4.   Al-Safi ZA, Shavell VI, Gonik B. Vaccination in pregnancy. Womens Health (Lond Engl). 2011 Jan; 7(1):109-19.

5.   Amodio E, Anastasi G, Marsala MG, Torregrossa MV, Romano N, Firenze A. Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy). Vaccine. 2011 Feb 4; 29(7):1408-12.

6.   Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA. Impact of Rotavirus Vaccination on Hospital-Acquired Rotavirus Gastroenteritis in Children. Pediatrics. 2011 Jan 24. [Epub ahead of print].

7.   Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine. 2011 Jan 4. [Epub ahead of print].

8.   Arnoldussen DL, Linehan M, Sheikh A. BCG vaccination and allergy: a systematic review and meta-analysis. J Allergy Clin Immunol. 2011 Jan; 127(1):246-53.

9.   Bhutta ZA, Khan MI, Soofi SB, Ochiai RL. New advances in typhoid Fever vaccination strategies. Adv Exp Med Biol. 2011; 697:17-39.

10.  Birmingham E, Catallozzi M, Findley SE, Vawdrey DK, Kukafka R, Stockwell MS. FluAlert: A qualitative evaluation of providers' desired characteristics and concerns regarding computerized influenza vaccination alerts. Prev Med. 2011 Jan 26. [Epub ahead of print].

11.  Bloom DE. The value of vaccination. Adv Exp Med Biol. 2011; 697:1-8.

12.  Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM. Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review. Pharmacoeconomics. 2011 Jan 21. [Epub ahead of print].

13.  Braillon A. HBV vaccination coverage among health-care workers. Eur J Public Health. 2011 Jan 7. [Epub ahead of print].

14.  Busse WW, Peters SP, Fenton MJ, Mitchell H, Bleecker ER, Castro M, Wenzel S, Erzurum SC, Fitzpatrick AM, Teague WG, Jarjour N, Moore WC, Sumino K, Simeone S, Ratanamaneechat S, Penugonda M, Gaston B, Ross TM, Sigelman S, Schiepan JR, Zaccaro DJ, Crevar CJ, Carter DM, Togias A. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol. 2011 Jan; 127(1):130-7, 137.e1-3.

15.  Carvalho-Costa FA, Volotão Ede M, de Assis RM, Fialho AM, de Andrade Jda S, Rocha LN, Tort LF, da Silva MF, Gómez MM, de Souza PM, Leite JP. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S35-41.

16.  Chen MF, Wang RH, Schneider JK, Tsai CT, Jiang DD, Hung MN, Lin LJ. Using the health belief model to understand caregiver factors influencing childhood influenza vaccinations. J Community Health Nurs. 2011 Jan; 28(1):29-40.

17.  Cho BH, Hicks KA, Honeycutt AA, Hupert N, Khavjou O, Messonnier M, Washington ML. A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics. J Public Health Manag Pract. 2011 Jan-Feb; 17(1):E22-8.

18.  Cohen SA, Chui KK, Naumova EN. Influenza Vaccination in Young Children Reduces Influenza-Associated Hospitalizations in Older Adults, 2002-2006. J Am Geriatr Soc. 2011 Jan 28. [Epub ahead of print].

19.  Crawford VL, O'Hanlon A, McGee H. The effect of patient characteristics upon uptake of the influenza vaccination: a study comparing community-based older adults in two healthcare systems. Age Ageing. 2011 Jan; 40(1):35-41.

20.  Cullen G, Baden RP, Cheifetz AS. Vaccination in inflammatory bowel disease. Am J Gastroenterol. 2011 Jan; 106(1):168.

21.  de Carvalho CX, Kipnis A, Thörn L, de Andrade JG, Pimenta F, Brandileone MC, Zanella RC, Flannery B, Sgambatti S, Andrade AL. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination. Vaccine. 2011 Feb 4; 29(7):1438-42.

22.  Ditschkowski M, Elmaagacli AH, Beelen DW. H1N1 in allogeneic stem cell recipients: courses of infection and influence of vaccination on graft-versus-host-disease (GVHD). Ann Hematol. 2011 Jan; 90(1):117-8.

23.  Dorner TE, Ràsky E, Stein KV, Stronegger WJ, Kautzky-Willer A, Rieder A. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men. Wien Med Wochenschr. 2011 Jan 25. [Epub ahead of print].

24.  Durham MJ, Goad JA, Neinstein LS, Lou M. A comparison of pharmacist travel-health specialists' versus primary care providers' recommendations for travel-related medications, vaccinations, and patient compliance in a college health setting. J Travel Med. 2011 Jan-Feb; 18(1):20-5.

25.  Eberly MD, Gorman GH, Eide MB, Olsen CH, Rajnik M. The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents. Vaccine. 2011 Jan 17; 29(4):650-9.

26.  Eggertson L. Experts call for national immunization registry, coordinated schedules. CMAJ. 2011 Jan 17. [Epub ahead of print].

27.  Fabry P, Gagneur A, Pasquier JC. Determinants of A (H1N1) vaccination: Cross-sectional study in a population of pregnant women in Quebec. Vaccine. 2011 Jan 8. [Epub ahead of print].

28.  Faye B, Ndiaye M, Ndiaye JL, Annie A, Tine RC, Lo AC, Ndiaye M, Sow D, De Sousa A, Gaye O. Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal.  Parasitol Res. 2011 Jan 5. [Epub ahead of print].

29.  Ferdinands JM, Belongia EA, Nwasike C, Shay DK. Influenza vaccination status is not associated with influenza testing among children: Implications for observational studies of vaccine effectiveness. Vaccine. 2011 Jan 8. [Epub ahead of print].

30.  Foster D, Walker AS, Paul J, Griffiths D, Knox K, Peto TE, Crook DW; Oxford Invasive Pneumococcal Surveillance Group. Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England. J Med Microbiol. 2011 Jan; 60(Pt 1):91-7. 

31.  Fu F, Rosenbloom DI, Wang L, Nowak MA. Imitation dynamics of vaccination behaviour on social networks. Proc Biol Sci. 2011 Jan 7; 278(1702):42-9.

32.  Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol. 2011 Jan 26. [Epub ahead of print].

33.  Garattini L, Padula A. To model or not to model: lessons from two vaccinations. Eur J Health Econ. 2011 Jan 26. [Epub ahead of print].

34.  Gargano LM, Painter JE, Sales JM, Morfaw C, Jones LM, Murray D, Wingood GM, Diclemente RJ, Hughes JM. Seasonal and 2009 H1N1 influenza vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination among secondary school teachers and staff. Hum Vaccin. 2011 Jan 1; 7(1).

35.  Gavazzi G, Filali-Zegzouti Y, Guyon AC, De Wazieres B, Lejeune B, Golmard JL, Belmin J, Piette F, Rothan-Tondeur M; On Behalf of the French Geriatric Infection Risk Institute (ORIG). French healthcare workers in geriatric healthcare settings staunchly opposed to influenza vaccination: The VESTA study. Vaccine. 2011 Jan 4. [Epub ahead of print].

36.  Gidudu J, Sack DA, Pina M, Hudson MJ, Kohl KS, Bishop P, Chatterjee A, Chiappini E, Compingbutra A, da Costa C, Fernandopulle R, Fischer TK, Haber P, Masana W, de Menezes MR, Kang G, Khuri-Bulos N, Killion LA, Nair C, Poerschke G, Rath B, Salazar-Lindo E, Setse R, Wenger P, Wong VC, Zaman K; The Brighton Collaboration Diarrhea Working Group. Diarrhea: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011 Jan 29; 29(5):1053-1071.

37.  Gladstone RA, Jefferies JM, Faust SN, Clarke SC. Continued control of pneumococcal disease in the UK - the impact of vaccination. J Med Microbiol. 2011 Jan; 60(Pt 1):1-8.

38.  Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011 Jan 29; 29(5):994-9.

39.  Grant LA, Dunne EF, Chesson H, Markowitz LE. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States. Vaccine. 2011 Jan 27. [Epub ahead of print].

40.  Greenhawt MJ, Li JT, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Ann Allergy Asthma Immunol. 2011 Jan; 106(1):11-6.

41.  Gupta PN, Vyas SP. Colloidal Carrier Systems for Transcutaneous Immunization. Curr Drug Targets. 2011 Jan 11. [Epub ahead of print].

42.  Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine. 2011 Jan 10; 29(3):370-7.

43.  Hara M, Mizuochi T, Kawano G, Koike T, Shibuya I, Ohya T, Ohbu K, Nagai K, Nagamitsu S, Yamashita Y, Nakayama T, Matsuishi T. A case of clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination. Brain Dev. 2011 Jan 25. [Epub ahead of print].

44.  Haviland AM, Elliott MN, Hambarsoomian K, Lurie N. Immunization disparities by Hispanic ethnicity and language preference. Arch Intern Med. 2011 Jan 24; 171(2):158-65.

45.  Hechter RC, Chao C, Li Q, Jacobsen SJ, Tseng HF. SECOND-DOSE VARICELLA VACCINATION COVERAGE IN CHILDREN AND ADOLESCENTS IN A MANAGED CARE ORGANIZATION IN CALIFORNIA, 2006-2009. Pediatr Infect Dis J. 2011 Jan 28. [Epub ahead of print]. 

46.  Heine G, Drozdenko G, Lahl A, Unterwalder N, Mei H, Volk HD, Dörner T, Radbruch A, Worm M. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr. 2011 Jan 12. [Epub ahead of print].

47.  Hubble MW, Zontek TL, Richards ME. Predictors of Influenza Vaccination among Emergency Medical Services Personnel. Prehosp Emerg Care. 2011 Jan 12. [Epub ahead of print].

48.  Influenza Division, National Center for Immunization and Respiratory Diseases. Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza--- Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Surveill Summ. 2011 Jan 21; 60(1):1-28.

49.  Joesoef MR, Leung J, Harpaz R, Bialek SR. Potential coding error of herpes zoster (HZ) vaccination and HZ diagnosis in administrative data. Vaccine. 2011 Jan 7. [Epub ahead of print].

50.  Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: connecticut--2005-2008. J Infect Dis. 2011 Feb; 203(4):509-12.

51.  Kharbanda EO, Vargas CY, Castaño PM, Lara M, Andres R, Stockwell MS. Exploring pregnant women's views on influenza vaccination and educational text messages. Prev Med. 2011 Jan; 52(1):75-7.

52.  Kim EY, Lee MS. Related factors of age-appropriate immunization among urban-rural children aged 24-35 months in a 2005 population-based survey in Nonsan, Korea. Yonsei Med J. 2011 Jan 1; 52(1):104-12.

53.  Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S48-53.

54.  Koenig HC, Sutherland A, Izurieta HS, McGonagle D. Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination. Vaccine. 2011 Jan 29; 29(5):913-9.

55.  Kofoed K, Rønholt F, Gerstoft J, Sand C. [Prevention of herpes zoster by vaccination]. Ugeskr Laeger. 2011 Jan 10; 173(2):110-4.

56.  Koppi S, Faé P, Hartmann G, Höftberger R, Holzmann H. [Fatal outcome of tick-borne encephalitis despite complete active vaccination.]. Nervenarzt. 2011 Jan 6. [Epub ahead of print].

57.  Kweon MN. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. Cytokine. 2011 Jan 14. [Epub ahead of print].

58.  Lacey CJ, Garnett GP. Promising control of genital warts: but is elimination possible? Lancet Infect Dis. 2011 Jan; 11(1):4-6.

59.  Lanza GA, Barone L, Scalone G, Pitocco D, Sgueglia GA, Mollo R, Nerla R, Zaccardi F, Ghirlanda G, Crea F. Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function. J Intern Med. 2011 Jan; 269(1):118-25.

60.  Lee BY, Bacon KM, Donohue JM, Wiringa AE, Bailey RR, Zimmerman RK. From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination. Vaccine. 2011 Jan 6. [Epub ahead of print].

61.  Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, De Zeng T, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China. Vaccine. 2011 Jan 8. [Epub ahead of print].

62.  Lopez AS, Zhang J, Brown C, Bialek S. Varicella-Related Hospitalizations in the United States, 2000-2006: The 1-Dose Varicella Vaccination Era. Pediatrics. 2011 Jan 3. [Epub ahead of print].

63.  Lu CC, Wang YC, Lai JH, Lee TS, Lin HT, Chang DM. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine. 2011 Jan 10; 29(3):444-50.

64.  Martins WD, Ribeiro MD, Oliveira LB, Barros LD, Jorge AC, Santos CM, Almeida DD, Cabral IF, Souza RT, Furquim TA. [Influenza and pneumococcal vaccination in heart failure: a little applied recommendation.]. Arq Bras Cardiol. 2011 Jan 21. [Epub ahead of print].

65.  McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study. Influenza Other Respi Viruses. 2011 Jan; 5(1):7-11.

66.  Michel JP, Lang PO. Promoting Life Course Vaccination. Rejuvenation Res. 2011 Jan 5. [Epub ahead of print].

67.  Miura K, Zhou H, Diouf A, Tullo G, Moretz SE, Aebig JA, Fay MP, Miller LH, Doumbo OK, Sagara I, Dicko A, Long CA, Ellis RD. Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized. Vaccine. 2011 Jan 27. [Epub ahead of print].

68.  Mohan V, Unnikrishnan R, Thomas N, Bhansali A, Wangnoo SK, Thomas K. Pneumococcal infections and immunization in diabetic patients. J Postgrad Med. 2011 Jan 5. [Epub ahead of print].

69.  Mortimer PP. The diphtheria vaccine debacle of 1940 that ushered in comprehensive childhood immunization in the United Kingdom. Epidemiol Infect. 2011 Jan 13:1-7. [Epub ahead of print].

70.  Mudry P, Vavrina M, Mazanek P, Machalova M, Litzman J, Sterba J. Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination. Arch Dis Child. 2011 Jan 10. [Epub ahead of print].

71.  Mutua MK, Kimani-Murage E, Ettarh RR. Childhood vaccination in informal urban settlements in Nairobi, Kenya: Who gets vaccinated? BMC Public Health. 2011 Jan 4; 11(1):6.

72.  Natan MB, Aharon O, Palickshvili S, Gurman V. Attitude of israeli mothers with vaccination of their daughters against human papilloma virus. J Pediatr Nurs. 2011 Jan; 26(1):70-7.

73.  Nelson CA, France EK, Shetterly SM, Glanz JM. Seasonal Influenza Vaccination Status Among Children With Laboratory Evidence of Pandemic H1N1 Infection. Pediatr Infect Dis J. 2011 Jan 18. [Epub ahead of print].

74.  Oberg AL, Dhiman N, Grill DE, Ryan JE, Kennedy RB, Poland GA. Optimizing High Dimensional Gene Expression Studies for Immune Response Following Smallpox Vaccination Using Taqman® Low Density Immune Arrays. J Immunol Methods. 2011 Jan 27. [Epub ahead of print].

75.  Painvin C, Schlumberger M, Chhem DB, Savannarom D, Phong P, Gilberg S. [Positive impact of a video and TV documentary on attendance of women to catch-up collective vaccinations and reasons for non-attendance.]. Bull Soc Pathol Exot. 2011 Jan 28. [Epub ahead of print].

76.  Park S, Nahm MH. Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun. 2011 Jan; 79(1):314-20.

77.  Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S1-5.

78.  Pesek R, Lockey R. Vaccination of adults with asthma and COPD. Allergy. 2011 Jan; 66(1):25-31.

79.  Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, Otheo E, Balboa F, Ríos E, Méndez C; Heracles Study Group. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol. 2011 Jan; 18(1):89-94.

80.  Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Del Castillo F, Hernández-Sampelayo T, Bueno M, Calvo C, Ríos E, Méndez C; on Behalf of the HERACLES Study Group. Laboratory-based, 2-year Surveillance of Pediatric Parapneumonic Pneumococcal Empyema Following Heptavalent Pneumococcal Conjugate Vaccine Universal Vaccination in Madrid. Pediatr Infect Dis J. 2011 Jan 24. [Epub ahead of print].

81.  Pissuwan D, Nose K, Kurihara R, Kaneko K, Tahara Y, Kamiya N, Goto M, Katayama Y, Niidome T. A solid-in-oil dispersion of gold nanorods can enhance transdermal protein delivery and skin vaccination. Small. 2011 Jan 17; 7(2):215-20.

82.  Placzek H, Madoff LC. The use of immunization registry-based data in vaccine effectiveness studies. Vaccine. 2011 Jan 10; 29(3):399-411.

83.  Plennevaux E, Blatter M, Cornish MJ, Go K, Kirby D, Wali M, Reeves-Hoché MK, Denis M. Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial. Vaccine. 2011 Jan 8. [Epub ahead of print].

84.  Poland GA, Jacobson RM. The age-old struggle against the antivaccinationists. N Engl J Med. 2011 Jan 13; 364(2):97-9.

85.  Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S11-5.

86.  Reluga TC, Galvani AP. A general approach for population games with application to vaccination. Math Biosci. 2011 Jan 27. [Epub ahead of print].

87.  Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L. The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis. 2011 Jan 25; 5(1):e952.

88.  Räsänen S, Lappalainen S, Halkosalo A, Salminen M, Vesikari T. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination. Scand J Infect Dis. 2011 Jan; 43(1):58-63.

89.  Sauerbrei A. Preventing congenital varicella syndrome with immunization. CMAJ. 2011 Jan 24. [Epub ahead of print].

90.  Saville AW, Albright K, Nowels C, Barnard J, Daley MF, Stokley S, Irby K, Kempe A. Getting Under the Hood: Exploring Issues That Affect Provider-Based Recall Using an Immunization Information System. Acad Pediatr. 2011 January - February; 11(1):44-49.

91.  Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E. Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol. 2011 Jan; 27(1):40-7.

92.  Sejvar JJ. Neurological infections: influenza in the spotlight. Lancet Neurol. 2011 Jan; 10(1):16-8.

93.  Semple PL, Watkins M, Davids V, Krensky AM, Hanekom WA, Kaplan G, Ress S. Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol. 2011; 2011:438463.

94.  Senior K. New vaccination technologies that make needles redundant. Lancet Infect Dis. 2011 Jan; 11(1):16-7. 

95.  Serpa JA, Valayam J, Musher D, Rossen R, Pirofski LA, Rodriguez-Barradas MC. VH3-Antibody Response to Immunization with Pneumococcal Polysaccharide Vaccine in Middle-aged and Elderly Persons. Clin Vaccine Immunol. 2011 Jan 12. [Epub ahead of print].

96.  Shen AK, Sobzcyk E, Buchanan A, Wu L, Duggan-Goldstein S. Second National Immunization Congress 2010: Addressing vaccine financing for the future in the United States. Hum Vaccin. 2011 Jan 1; 7(1). [Epub ahead of print].

97.  Shoda A, Hayashi M, Takayama N, Oshima K, Nishikawa M, Okazaki T, Negishi M, Hayashida S, Watanabe H, Inaba N. Maternal screening and postpartum vaccination for measles infection in Japan: a cohort study. BJOG. 2011 Jan; 118(1):88-92.

98.  Silva ML, Martins MA, Espírito-Santo LR, Campi-Azevedo AC, Silveira-Lemos D, Ribeiro JG, Homma A, Kroon EG, Teixeira-Carvalho A, Elói-Santos SM, Martins-Filho OA. Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults. Vaccine. 2011 Jan 10; 29(3):583-92.

99.  Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011 Jan 25; 2(1).

100. Slade BA, Gee J, Broder KR, Vellozzi C. Comment on the contribution by Souayah et al., "Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009". Vaccine. 2011 Jan 29; 29(5):865-6. 

101. Smith HL, Monath TP, Pazoles P, Rothman AL, Casey DM, Terajima M, Ennis FA, Guirakhoo F, Green S. Development of Antigen-Specific Memory CD8+ T Cells Following Live-Attenuated Chimeric West Nile Virus Vaccination. J Infect Dis. 2011 Feb; 203(4):513-22.

102. Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI. Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine. 2011 Jan 29; 29(5):886-9.

103. Steinhoff MC. Influenza in young children: burden, immunisation, and policy. Lancet Infect Dis. 2011 Jan; 11(1):2-3.

104.  Syriopoulou V, Kafetzis D, Theodoridou M, Syrogiannopoulos GA, Mantagos S, Trimis G, Mavrikou M, Konstantopoulos A. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta Paediatr. 2011 Jan 12. [Epub ahead of print].

105. Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S56-60.

106. Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda. Vaccine. 2011 Jan 15. [Epub ahead of print].

107. Thamthitiwat S, Marin N, Baggett HC, Peruski LF, Kiatkulwiwat W, Panumatrasmee V, Varma JK, Nateniyom S, Akarasewi P, Maloney SA. Mycobacterium bovis (Bacille Calmette-Guérin) bacteremia in immunocompetent neonates following vaccination. Vaccine. 2011 Jan 5. [Epub ahead of print].

108. Thomas EA, Goldstone SE. Should I or shouldn't I: decision making, knowledge and behavioral effects of quadrivalent HPV vaccination in men who have sex with men. Vaccine. 2011 Jan 10; 29(3):570-6.

109. Tro-Baumann B, von Spiczak S, Lotte J, Bast T, Haberlandt E, Sassen R, Freund A, Leiz S, Stephani U, Boor R, Holthausen H, Helbig I, Kluger G. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia. 2011 Jan; 52(1):175-8.

110. Ulloa-Gutierrez R, Boza R, Carvajal-Riggioni D, Baltodano A. Pertussis: should we improve intensive care management or vaccination strategies? Expert Rev Vaccines. 2011 Jan; 10(1):49-53.

111. Van Buynder PG, Carcione D, Rettura V, Daly A, Woods E. Marketing paediatric influenza vaccination: results of a major metropolitan trial. Influenza Other Respi Viruses. 2011 Jan; 5(1):33-8.

112. van Dissel JT, Soonowala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P. Ag85B-ESAT-6 adjuvanted with IC31(®) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine. 2011 Jan 19. [Epub ahead of print].

113. Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, de Valk H, Lévy-Bruhl D. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health. 2011 Jan 12; 11(1):30.

114. Warrell MJ. Intradermal Rabies Vaccination: The Evolution and Future of Pre-and Post-exposure Prophylaxis. Curr Top Microbiol Immunol. 2011 Jan 26. [Epub ahead of print].

115. Willi B, Fahnenstich H, Weber P. Encephalitis after vaccination against H1N1 influenza virus. Eur J Paediatr Neurol. 2011 Jan 28. [Epub ahead of print].

116. Womersley K. Vaccination programme to protect children against pneumonia and diarrhoea needs more funds. BMJ. 2011 Jan 25; 342:d534.

117. Wu J, Zhong X, Li CK, Zhou JF, Lu M, Huang KY, Dong M, Liu Y, Luo FJ, Du N, Chui C, Liu LQ, Smith NM, Li B, Shi NM, Song LF, Gao Y, Wang DY, Wang X, Zhu WF, Yan Y, Li Z, Chen JT, McMichael AJ, Yin WD, Xu XN, Shu Y. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine. 2011 Jan 29; 29(5):1009-16.

118. Yazdanbakhsh M, Luty AJ. Wormy mothers, healthy babies: case closed or conundrum? Lancet. 2011 Jan 1; 377(9759):6-8.

119. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, Parashar UD, Patel MM. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in el salvador. Pediatr Infect Dis J. 2011 Jan; 30(1 Suppl):S6-S10.

120. Yoo BK, Kasajima M, Phelps CE, Fiscella K, Bennett NM, Szilagyi PG. Influenza vaccine supply and racial/ethnic disparities in vaccination among the elderly. Am J Prev Med. 2011 Jan; 40(1):1-10.

121. Youngster I, Kozer E, Lazarovitch Z, Broide E, Goldman M. Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch Dis Child. 2011 Jan 24. [Epub ahead of print].

122. Zarocostas J. Experts urge vaccination to try to control cholera outbreak in Haiti. BMJ. 2011 Jan 5; 342:d23.

123. Zimet GD, Stupiansky NW, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Influence of patient's relationship status and HPV history on physicians' decisions to recommend HPV vaccination. Vaccine. 2011 Jan 10; 29(3):378-81.

124. Zárate-Bladés CR, Silva CL, Passos GA. The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy. Clin Dev Immunol. 2011;2011:192630.

 [top]